aplastic anemia | Page 84 | Aplastic Anemia & MDS International Foundation Return to top.

aplastic anemia

Survival of patients with documented autologous recovery after SCT for severe aplastic anemia: a study by the WPSAA of the EBMT.

Author(s): 
Piccin A, McCann S, Socié G, Oneto R, Bacigalupo A, Locasciulli A, Marsh J, Schrezenmeier H, Tichelli A, Hand E, Lawler M, Passweg J; Aplastic Anaemia Working Party of the European Group for Blood and Marrow Transplantation.
Primary Author: 
Piccin A
Journal Title: 
Biol Blood Marrow Transplant
Original Publication Date: 
Nov 2009

Graft rejection, with persistent pancytopenia, is well documented after allogeneic BMT (hematopoietic SCT

Bone Marrow Disease(s): 

Fludarabine, cyclophosphamide, antithymocyte globulin, with or without low dose total body irradiation, for alternative donor transplants, in acquired severe aplastic anemia: a retrospective study from the EBMT-SAA working party.

Author(s): 
Bacigalupo A, Socie' G, Lanino E, Prete A, Locatelli F, Locasciulli A, Cesaro S, Shimoni A, Marsh J, Brune M, Van Lint MT, Oneto R, Passweg J; Severe Aplastic Anemia Working Party of the European Group for Blood and Marrow Transplantation.
Primary Author: 
Bacigalupo A
Journal Title: 
Haematologica
Original Publication Date: 
May 2010

BACKGROUND:

We analyzed

Bone Marrow Disease(s): 

Paroxysmal nocturnal hemoglobinuria clones in severe aplastic anemia patients treated with horse anti-thymocyte globulin plus cyclosporine.

Author(s): 
Scheinberg P, Marte M, Nunez O, Young NS.
Primary Author: 
Scheinberg P
Journal Title: 
Haematologica
Original Publication Date: 
Jul 2010

BACKGROUND:

Clones of glycosylphosphatidylinositol-anchor protein-deficient cells are

Bone Marrow Disease(s): 

Retrospective survey on the prevalence and outcome of prior autoimmune diseases in patients with aplastic anemia reported to the registry of the European group for blood and marrow transplantation.

Author(s): 
Cesaro S, Marsh J, Tridello G, Rovò A, Maury S, Montante B, Masszi T, Van Lint MT, Afanasyev B, Iriondo Atienza A, Bierings M, Carbone C, Doubek M, Lanino E, Sarhan M, Risitano A, Steinerova K, Wahlin A, Pegoraro A, Passweg J.
Primary Author: 
Cesaro S
Journal Title: 
Acta Haematol
Original Publication Date: 
Jul 2010

BACKGROUND:

Bone Marrow Disease(s): 

Th17 immune responses contribute to the pathophysiology of aplastic anemia.

Author(s): 
de Latour RP, Visconte V, Takaku T, Wu C, Erie AJ, Sarcon AK, Desierto MJ, Scheinberg P, Keyvanfar K, Nunez O, Chen J, Young NS
Primary Author: 
de Latour RP
Journal Title: 
Blood
Original Publication Date: 
Aug 2010

T helper type 17 (Th17) cells have been characterized based on production of interleukin-17 (IL-17) and association with autoimmune diseases. We studied the role of Th17

Bone Marrow Disease(s): 
Share with addtoany.com.